688114 Stock Overview
MGI Tech Co., Ltd. engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 688114 from our risk checks.
MGI Tech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥59.00 |
| 52 Week High | CN¥106.68 |
| 52 Week Low | CN¥50.30 |
| Beta | 0 |
| 1 Month Change | 2.47% |
| 3 Month Change | -20.37% |
| 1 Year Change | -24.17% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.00% |
Recent News & Updates
Shareholder Returns
| 688114 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 1.4% | 4.7% | 2.2% |
| 1Y | -24.2% | -31.9% | -10.2% |
Return vs Industry: 688114 exceeded the CN Life Sciences industry which returned -31.9% over the past year.
Return vs Market: 688114 underperformed the CN Market which returned -10.2% over the past year.
Price Volatility
| 688114 volatility | |
|---|---|
| 688114 Average Weekly Movement | 5.6% |
| Life Sciences Industry Average Movement | 7.8% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in CN Market | 11.0% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 688114's share price has been volatile over the past 3 months.
Volatility Over Time: 688114's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 2,867 | Dejian Yu | en.mgi-tech.com |
MGI Tech Co., Ltd. engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries. in China and internationally. Its products include sequencers, such as genetic sequencers, sequencing reagents, library prep kits, and bioinformatics analysis; lab automation products, which includes automation system and sample treatment kits; and novel products, comprising single-cell platform, ultrasound platform, and BIT platform.
MGI Tech Co., Ltd. Fundamentals Summary
| 688114 fundamental statistics | |
|---|---|
| Market cap | CN¥25.35b |
| Earnings (TTM) | -CN¥658.67m |
| Revenue (TTM) | CN¥2.82b |
8.6x
P/S Ratio-36.9x
P/E RatioIs 688114 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688114 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.82b |
| Cost of Revenue | CN¥1.32b |
| Gross Profit | CN¥1.51b |
| Other Expenses | CN¥2.17b |
| Earnings | -CN¥658.67m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.60 |
| Gross Margin | 53.40% |
| Net Profit Margin | -23.33% |
| Debt/Equity Ratio | 4.1% |
How did 688114 perform over the long term?
See historical performance and comparison